Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
Nonintravenous rescue medications for pediatric status epilepticus: A cost-effectiveness analysis
| Indexado |
|
||||
| DOI | 10.1111/EPI.13812 | ||||
| Año | 2017 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
Significance: For pediatric status epilepticus, buccal midazolam and nasal midazolam are the most cost-effective nonintravenous rescue medications in the United States. Rectal diazepam is not a cost-effective alternative, and this conclusion remains extremely robust to wide variations of the input parameters.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Sanchez Fernandez, Ivan | Hombre |
Harvard Med Sch - Estados Unidos
Univ Barcelona - España Children's Hospital Boston - Estados Unidos Universitat de Barcelona - España |
| 2 | Gainza-Lein, Marina | Mujer |
Harvard Med Sch - Estados Unidos
Universidad Austral de Chile - Chile Children's Hospital Boston - Estados Unidos |
| 3 | Loddenkemper, Tobias | Hombre |
Harvard Med Sch - Estados Unidos
Children's Hospital Boston - Estados Unidos |
| Fuente |
|---|
| Pediatric Epilepsy Research Foundation |
| Epilepsy Foundation of America |
| Lundbeck |
| Acorda |
| Eisai |
| Epilepsy Therapy Project |
| Epilepsy Research Fund |
| Fundacion Alfonso Martin Escudero |
| HHV-6 Foundation |
| Pfizer |
| Patient-Centered Outcomes Research Institute |
| American Epilepsy Society |
| Upsher-Smith |
| Epilepsy Foundation |
| American Clinical Neurophysiology Society |
| Citizens United for Research in Epilepsy |
| H. Lundbeck A/S |
| American Academy of Neurology |
| Fundación Alfonso MartÃn Escudero |
| Zogenix |
| American Board of Clinical Neurophysiology |
| Agradecimiento |
|---|
| Ivan Sanchez Fernandez has received funding from Fundacion Alfonso Martin Escudero and the HHV-6 Foundation. Marina Gainza-Lein reports no disclosures. Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Treasurer) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, as Contributing Editor for Epilepsy Currents, and as an Associate Editor for Wyllie's Treatment of Epilepsy: Principles and Practice, 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund, the American Epilepsy Society, the Epilepsy Foundation of America, the Epilepsy Therapy Project, Patient-Centered Outcomes Research Institute, the Pediatric Epilepsy Research Foundation, Citizens United for Research in Epilepsy, the and HHV-6 Foundation, and has received research grants from Lundbeck, Eisai, Upsher-Smith, Acorda, and Pfizer. He serves as a consultant for Zogenix, Upsher-Smith, and Lundbeck. He performs video-electroencephalography long-term and ICU monitoring, electroencephalography, and other electrophysiologic studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures, and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the American Academy of Neurology, American Epilepsy Society, and American Clinical Neurophysiology Society, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video-electroencephalography long-term and ICU monitoring, electroencephalography, and other electrophysiologic studies and bills for these procedures, and she evaluates pediatric neurology patients and bills for clinical care. |
| Iván Sánchez Fernández has received funding from Fundación Alfonso Martín Escudero and the HHV-6 Foundation. Marina Gaínza-Lein reports no disclosures. Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Treasurer) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, as Contributing Editor for Epilepsy Currents, and as an Associate Editor for Wyllie's Treatment of Epilepsy: Principles and Practice, 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund, the American Epilepsy Society, the Epilepsy Foundation of America, the Epilepsy Therapy Project, Patient-Centered Outcomes Research Institute, the Pediatric Epilepsy Research Foundation, Citizens United for Research in Epilepsy, the and HHV-6 Foundation, and has received research grants from Lundbeck, Eisai, Upsher-Smith, Acorda, and Pfizer. He serves as a consultant for Zogenix, Upsher-Smith, and Lundbeck. He performs video-electroencephalography long-term and ICU monitoring, electroencephalography, and other electrophysiologic studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures, and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the American Academy of Neurology, American Epilepsy Society, and American Clinical Neurophysiology Society, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video-electroencephalography long-term and ICU monitoring, electroencephalography, and other electrophysiologic studies and bills for these procedures, and she evaluates pediatric neurology patients and bills for clinical care. |
